Survey Assessing How Consumers Adapt Their Diet in Response to Health Claim Messaging
NCT05088863 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 384
Last updated 2024-11-29
Summary
A survey designed to examine how consumers adapt their diet in response to health claim messaging.
Conditions
- Health Claim Implementation
Interventions
- OTHER
-
flaxseed
40g of flaxseed per day
Sponsors & Collaborators
-
Agriculture and Agri-Food Canada
collaborator OTHER_GOV -
St. Boniface Hospital
lead OTHER
Principal Investigators
-
Heather Blewett, PhD · Agriculture and Agri-Food Canada
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-03
- Primary Completion
- 2025-11-30
- Completion
- 2025-11-30
Countries
- Canada
Study Locations
More Related Trials
-
Intervention With Legume Kernel Fibre in Healthy Subjects
NCT01036308 ·Status: COMPLETED ·Phase: NA
-
Effects of Flaxseed Supplementation in Metabolic Syndrome
NCT02497352 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Exercise and Flax-Based Nutritional Supplementation for Lowering Cholesterol
NCT00204412 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Sterol Enhanced Soy Beverage on Cholesterol Metabolism, Inflammation and Oxidative Status in Humans
NCT00924391 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of High-oleic Canola and Flaxseed Oils for Hypercholesterolemia and Cardiovascular Disease Risk Factors
NCT00927199 ·Status: COMPLETED ·Phase: PHASE2
-
Single Oral Dose of BeneFlax to Healthy Young and Older Adults
NCT01531569 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Flaxseed on Lipid Uptake and Appetite
NCT00465036 ·Status: COMPLETED ·Phase: NA
-
Canola Oil Multicentre Intervention Trial
NCT01351012 ·Status: COMPLETED ·Phase: NA
-
Once-Daily Oral Dose of BeneFlax to Healthy Older Adults
NCT01846117 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Plant Sterol Enriched Milk on Plasma Lipid Levels of Humans Breast-fed During Infancy
NCT01825668 ·Status: UNKNOWN ·Phase: NA
-
Intervention With Lupin Kernel Fibre in Hypercholesterolemic Subjects
NCT01035086 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Sterol-Fortified Low Fat Soy Beverage on Cholesterol Metabolism, Inflammation and Oxidative Status in Humans - Study II
NCT00923403 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effects of a Nutrition Supplement on Health Related Quality of Life
NCT04499560 ·Status: COMPLETED ·Phase: NA
-
Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors
NCT00644098 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Viscous Soluble Fibers on Serum Cholesterol Levels
NCT02068248 ·Status: UNKNOWN
-
Effects of a Long Term Dietary Portfolio and of Sequential Removal of Food Components From the Diet
NCT00438893 ·Status: COMPLETED ·Phase: NA
-
The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject
NCT02410668 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease
NCT00781950 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol
NCT03649620 ·Status: COMPLETED ·Phase: NA
-
Effects of Soy Protein/Soy Fiber on Measures of Satiety
NCT01358318 ·Status: COMPLETED ·Phase: NA
-
Gut Health Response to Dietary Fiber
NCT01321736 ·Status: COMPLETED ·Phase: NA
-
Can Flaxseed Prevent Broken Hearts in Women With Breast Cancer Study?
NCT04632407 ·Status: UNKNOWN ·Phase: NA
-
Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer
NCT00794989 ·Status: TERMINATED ·Phase: NA
-
The Role of Gut Microbiome on Cardiovascular Health Benefits of Dietary Lignans (CardioFlax Study).
NCT04179136 ·Status: COMPLETED ·Phase: NA
-
Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol
NCT00981981 ·Status: COMPLETED ·Phase: PHASE2